Matthew Kelsey
Stock Analyst at HC Wainwright & Co.
(0.15)
# 4,470
Out of 5,130 analysts
7
Total ratings
25%
Success rate
-22.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Kelsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Assumes: Buy | $100 | $11.62 | +760.96% | 1 | Jun 2, 2025 | |
| ACXP Acurx Pharmaceuticals | Assumes: Buy | $160 | $2.93 | +5,360.75% | 1 | May 15, 2025 | |
| DBVT DBV Technologies | Maintains: Equal-Weight | $260 → $100 | $17.01 | +487.89% | 5 | Dec 20, 2018 |
Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $100
Current: $11.62
Upside: +760.96%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $160
Current: $2.93
Upside: +5,360.75%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260 → $100
Current: $17.01
Upside: +487.89%